Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease
- Author
- Daniel C. Butler MD, Shawn G. Kwatra MD
- Published
- Wed 25 Jun 2025
- Episode Link
- https://medicalspecialtiespodcast.simplecast.com/episodes/evidence-based-care-in-atopic-dermatitis-practical-considerations-for-il-13-inhibitors-for-moderate-to-severe-disease-3yehhmy9
In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:
- Patient candidacy considerations
- Treatment advancement strategies that go beyond topical therapies
- The importance of patient-centered care that address patients’ fears and needs
- A detailed patient case to highlight take home points
Presenter
Daniel C. Butler, MD
Assistant Dean Student Affairs
University of Arizona College of Medicine – Tucson
Tucson, Arizona
Shawn G. Kwatra, MD
Dr. Joseph W. Burnett Endowed Professor and Chair
Department of Dermatology
University of Maryland School of Medicine
Baltimore, Maryland
Program page:
https://bit.ly/4kTP04D
